EBACW (European Biotech Acquisition) Buildings And Improvements: $0.00 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EBACW European Biotech Acquisition Corp EBACW
22 GF Score
Price $0.52
View Full Analysis

What is European Biotech Acquisition Buildings And Improvements?

European Biotech Acquisition EBACW 22 Buildings And Improvements is $0.00 Mil as of Dec. 2022. GuruFocus rates EBACW with a GF Score™ of 22/100.

European Biotech Acquisition Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for European Biotech Acquisition's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Biotech Acquisition Buildings And Improvements Chart

European Biotech Acquisition Annual Data
Trend Dec21 Dec22
Buildings And Improvements
0.00 0.00

European Biotech Acquisition Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Buildings And Improvements Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
EBACW
22GF Score
European Biotech Acquisition Corp EBACW
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Biotech Acquisition Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of $0.00 Mil mean?
European Biotech Acquisition (EBACW) has a Buildings And Improvements of $0.00 Mil as of Dec. 2022. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on European Biotech Acquisition and its competitors.
Is European Biotech Acquisition's Buildings And Improvements too high?
European Biotech Acquisition's current Buildings And Improvements is $0.00 Mil. Overall, European Biotech Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does European Biotech Acquisition's Buildings And Improvements compare to CNTQ and LION?
European Biotech Acquisition's Buildings And Improvements of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Diversified Financial Services company?
A good Buildings And Improvements depends on the Diversified Financial Services industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on European Biotech Acquisition and its competitors. European Biotech Acquisition's current Buildings And Improvements is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Biotech Acquisition stock overvalued right now?
European Biotech Acquisition (EBACW) has a current Buildings And Improvements of $0.00 Mil. The current Buildings And Improvements is $0.00 Mil. European Biotech Acquisition's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For European Biotech Acquisition (EBACW), the current Buildings And Improvements is $0.00 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

European Biotech Acquisition Business Description

Address EPFL Innovation Park Building, Lausanne, CHE, 1015
European Biotech Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for EBACW

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price